Samumed fetches $438 mln
San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
6 August 2018•1 min read
San Diego-based Samumed, a small-molecule drug platform, has secured $438 million in funding. The investors were not named.
